BELLEVUE GROUP AG Holdings

BELLEVUE GROUP AG is an investment fund managing more than 6.97B US dollars. The largest holdings include Ionis Pharmaceuticals, Vertex Pharmaceuticals Incorporated and argenx SE. In Q3 2022 the fund bought assets of total value of 134.77M US dollars and sold assets of total value of 138.81M US dollars.

$6.96B

portfolio value

+2.13%

quarter

-27.50%

1 year

+15.39%

3 years

+51.50%

5 years

BELLEVUE GROUP AG portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q2 2016	74309000	106538000
Q3 2016	54405000	38399000
Q4 2016	34082000	74369000
Q1 2017	262120000	4645000
Q2 2017	157034000	67274000
Q3 2017	171300000	52937000
Q4 2017	119438000	112553000
Q1 2018	152022000	92976000
Q2 2018	226585000	78561000
Q3 2018	408936000	14370000
Q4 2018	177131000	194568000
Q1 2019	429435000	153297000
Q2 2019	4174541000	109244000
Q3 2019	-64828000	391293000
Q4 2019	969009000	103045000
Q1 2020	-266358000	808658000
Q2 2020	1084166000	748467000
Q3 2020	307195000	93012000
Q4 2020	1503576000	175208000
Q1 2021	1129141000	419672000
Q2 2021	875398000	93303000
Q3 2021	319778000	551191000
Q4 2021	603875000	508062000
Q1 2022	275291000	1201396000
Q2 2022	-355337000	1127313000
Q3 2022	134772000	138807000

BELLEVUE GROUP AG 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Ionis Pharmaceuticals, Inc. Portfolio share: 6.01% Portfolio value: 418.56M Avg. open price: $70.23 Current price: $38.98 P/L: -44.50% Sold -3.20% shares Q3 2022	share	6.01%	418.56M	$70.23	$38.98	-44.50%	Sold -3.20% shares Q3 2022
Biotechnology Vertex Pharmaceuticals Incorporated Portfolio share: 4.81% Portfolio value: 335.32M Avg. open price: $201.87 Current price: $317.6 P/L: +57.33% Sold -1.53% shares Q3 2022	share	4.81%	335.32M	$201.87	$317.6	+57.33%	Sold -1.53% shares Q3 2022
Biotechnology argenx SE Portfolio share: 4.76% Portfolio value: 331.85M Avg. open price: $134.18 Current price: $393.21 P/L: +193.05% Sold -1.55% shares Q3 2022	share	4.76%	331.85M	$134.18	$393.21	+193.05%	Sold -1.55% shares Q3 2022
Drug Manufacturers—Specialty & Generic Neurocrine Biosciences, Inc. Portfolio share: 4.35% Portfolio value: 303.24M Avg. open price: $89.17 Current price: $124 P/L: +39.05% Bought +0.38% shares Q3 2022	share	4.35%	303.24M	$89.17	$124	+39.05%	Bought +0.38% shares Q3 2022
Biotechnology Alnylam Pharmaceuticals, Inc. Portfolio share: 2.75% Portfolio value: 191.50M Avg. open price: $92.29 Current price: $226.4 P/L: +145.32% Sold -9.58% shares Q3 2022	share	2.75%	191.50M	$92.29	$226.4	+145.32%	Sold -9.58% shares Q3 2022
Biotechnology Moderna, Inc. Portfolio share: 2.65% Portfolio value: 184.44M Avg. open price: $15.19 Current price: $175.93 P/L: +1058.01% Sold -1.11% shares Q3 2022	share	2.65%	184.44M	$15.19	$175.93	+1058.01%	Sold -1.11% shares Q3 2022
Biotechnology Incyte Corporation Portfolio share: 2.62% Portfolio value: 182.87M Avg. open price: $87.16 Current price: $84.08 P/L: -3.53% Sold -1.05% shares Q3 2022	share	2.62%	182.87M	$87.16	$84.08	-3.53%	Sold -1.05% shares Q3 2022
Medical Instruments & Supplies Intuitive Surgical, Inc. Portfolio share: 2.42% Portfolio value: 168.33M Avg. open price: $214.4 Current price: $269.72 P/L: +25.80% Sold -1.24% shares Q3 2022	share	2.42%	168.33M	$214.4	$269.72	+25.80%	Sold -1.24% shares Q3 2022
Drug Manufacturers—Specialty & Generic Intra-Cellular Therapies, Inc. Portfolio share: 2.22% Portfolio value: 154.91M Avg. open price: $30.01 Current price: $54.25 P/L: +80.78% Sold -0.60% shares Q3 2022	share	2.22%	154.91M	$30.01	$54.25	+80.78%	Sold -0.60% shares Q3 2022
Medical Devices Axonics, Inc. Portfolio share: 2.22% Portfolio value: 154.48M Avg. open price: $50.64 Current price: $67.47 P/L: +33.24% Sold -5.21% shares Q3 2022	share	2.22%	154.48M	$50.64	$67.47	+33.24%	Sold -5.21% shares Q3 2022
Medical Devices Abbott Laboratories Portfolio share: 2.18% Portfolio value: 151.89M Avg. open price: $82.27 Current price: $105.38 P/L: +28.09% Sold -0.25% shares Q3 2022	share	2.18%	151.89M	$82.27	$105.38	+28.09%	Sold -0.25% shares Q3 2022
Healthcare Plans UnitedHealth Group Incorporated Portfolio share: 2.15% Portfolio value: 149.87M Avg. open price: $245.96 Current price: $535.04 P/L: +117.53% Sold -1.75% shares Q3 2022	share	2.15%	149.87M	$245.96	$535.04	+117.53%	Sold -1.75% shares Q3 2022
Medical Devices Boston Scientific Corporation Portfolio share: 2.11% Portfolio value: 147.33M Avg. open price: $38.46 Current price: $45.42 P/L: +18.10% Sold -1.20% shares Q3 2022	share	2.11%	147.33M	$38.46	$45.42	+18.10%	Sold -1.20% shares Q3 2022
Biotechnology Sage Therapeutics, Inc. Portfolio share: 1.67% Portfolio value: 116.33M Avg. open price: $103.04 Current price: $43.52 P/L: -57.77% Sold -0.08% shares Q3 2022	share	1.67%	116.33M	$103.04	$43.52	-57.77%	Sold -0.08% shares Q3 2022
Biotechnology Agios Pharmaceuticals, Inc. Portfolio share: 1.65% Portfolio value: 114.78M Avg. open price: $42.64 Current price: $29.8 P/L: -30.11% Sold -0.10% shares Q3 2022	share	1.65%	114.78M	$42.64	$29.8	-30.11%	Sold -0.10% shares Q3 2022
Biotechnology Jazz Pharmaceuticals plc Portfolio share: 1.58% Portfolio value: 109.81M Avg. open price: $153 Current price: $150.97 P/L: -1.33% Sold -10.25% shares Q3 2022	share	1.58%	109.81M	$153	$150.97	-1.33%	Sold -10.25% shares Q3 2022
Biotechnology Myovant Sciences Ltd. Portfolio share: 1.52% Portfolio value: 106.19M Avg. open price: $18.32 Current price: $26.81 P/L: +46.34% Sold -0.12% shares Q3 2022	share	1.52%	106.19M	$18.32	$26.81	+46.34%	Sold -0.12% shares Q3 2022
Biotechnology Arvinas, Inc. Portfolio share: 1.40% Portfolio value: 97.46M Avg. open price: $32.17 Current price: $39.53 P/L: +22.88% Bought +3.13% shares Q3 2022	share	1.40%	97.46M	$32.17	$39.53	+22.88%	Bought +3.13% shares Q3 2022
Medical Devices Stryker Corporation Portfolio share: 1.39% Portfolio value: 96.59M Avg. open price: $189.37 Current price: $237.9 P/L: +25.63% Sold -0.15% shares Q3 2022	share	1.39%	96.59M	$189.37	$237.9	+25.63%	Sold -0.15% shares Q3 2022
Diagnostics & Research Danaher Corporation Portfolio share: 1.36% Portfolio value: 94.90M Avg. open price: $167.47 Current price: $267.97 P/L: +60.01% Bought +0.93% shares Q3 2022	share	1.36%	94.90M	$167.47	$267.97	+60.01%	Bought +0.93% shares Q3 2022
Biotechnology Relay Therapeutics, Inc. Portfolio share: 1.35% Portfolio value: 94.06M Avg. open price: $35.25 Current price: $18.36 P/L: -47.92% Bought +4.28% shares Q3 2022	share	1.35%	94.06M	$35.25	$18.36	-47.92%	Bought +4.28% shares Q3 2022
Biotechnology Revolution Medicines, Inc. Portfolio share: 1.32% Portfolio value: 92.29M Avg. open price: $32.33 Current price: $24.32 P/L: -24.77% Bought +38.33% shares Q3 2022	share	1.32%	92.29M	$32.33	$24.32	-24.77%	Bought +38.33% shares Q3 2022
Healthcare Plans Elevance Health Inc. Portfolio share: 1.32% Portfolio value: 91.97M Avg. open price: N/A Current price: $522.34 P/L: N/A Sold -2.88% shares Q3 2022	share	1.32%	91.97M	N/A	$522.34	N/A	Sold -2.88% shares Q3 2022
Medical Devices Insulet Corporation Portfolio share: 1.23% Portfolio value: 85.78M Avg. open price: $201.13 Current price: $302.43 P/L: +50.36% Sold -3.20% shares Q3 2022	share	1.23%	85.78M	$201.13	$302.43	+50.36%	Sold -3.20% shares Q3 2022
Medical Devices Edwards Lifesciences Corporation Portfolio share: 1.22% Portfolio value: 84.75M Avg. open price: $60.58 Current price: $73.85 P/L: +21.90% Bought +1.49% shares Q3 2022	share	1.22%	84.75M	$60.58	$73.85	+21.90%	Bought +1.49% shares Q3 2022
Biotechnology Fate Therapeutics, Inc. Portfolio share: 1.20% Portfolio value: 83.95M Avg. open price: $44.87 Current price: $20.4 P/L: -54.53% Bought +5.52% shares Q3 2022	share	1.20%	83.95M	$44.87	$20.4	-54.53%	Bought +5.52% shares Q3 2022
Biotechnology Sarepta Therapeutics, Inc. Portfolio share: 1.20% Portfolio value: 83.55M Avg. open price: $91.72 Current price: $122.96 P/L: +34.06% Sold -33.66% shares Q3 2022	share	1.20%	83.55M	$91.72	$122.96	+34.06%	Sold -33.66% shares Q3 2022
Medical Care Facilities Option Care Health, Inc. Portfolio share: 1.19% Portfolio value: 82.74M Avg. open price: $22.82 Current price: $30.22 P/L: +32.40% Sold -8.94% shares Q3 2022	share	1.19%	82.74M	$22.82	$30.22	+32.40%	Sold -8.94% shares Q3 2022
Healthcare Plans Molina Healthcare, Inc. Portfolio share: 1.14% Portfolio value: 79.35M Avg. open price: $190.11 Current price: $335.11 P/L: +76.27% Sold -3.11% shares Q3 2022	share	1.14%	79.35M	$190.11	$335.11	+76.27%	Sold -3.11% shares Q3 2022
Medical Devices ShockWave Medical, Inc. Portfolio share: 1.10% Portfolio value: 76.78M Avg. open price: $52.71 Current price: $243.11 P/L: +361.25% Sold -25.51% shares Q3 2022	share	1.10%	76.78M	$52.71	$243.11	+361.25%	Sold -25.51% shares Q3 2022
Medical Devices Tandem Diabetes Care, Inc. Portfolio share: 1.08% Portfolio value: 74.93M Avg. open price: $93.79 Current price: $42.44 P/L: -54.75% Bought +19.01% shares Q3 2022	share	1.08%	74.93M	$93.79	$42.44	-54.75%	Bought +19.01% shares Q3 2022
Medical Instruments & Supplies Becton, Dickinson and Company Portfolio share: 1.07% Portfolio value: 74.61M Avg. open price: $235.39 Current price: $246.21 P/L: +4.60% Sold -2.37% shares Q3 2022	share	1.07%	74.61M	$235.39	$246.21	+4.60%	Sold -2.37% shares Q3 2022
Medical Devices Inspire Medical Systems, Inc. Portfolio share: 1.02% Portfolio value: 71.26M Avg. open price: $98.45 Current price: $234.96 P/L: +138.65% Sold -1.30% shares Q3 2022	share	1.02%	71.26M	$98.45	$234.96	+138.65%	Sold -1.30% shares Q3 2022
Medical Devices DexCom, Inc. Portfolio share: 0.99% Portfolio value: 69.30M Avg. open price: $163.97 Current price: $116.56 P/L: -28.91% Sold -7.33% shares Q3 2022	share	0.99%	69.30M	$163.97	$116.56	-28.91%	Sold -7.33% shares Q3 2022
Biotechnology Insmed Incorporated Portfolio share: 0.99% Portfolio value: 69.24M Avg. open price: $28.33 Current price: $19.89 P/L: -29.78% Sold -11.23% shares Q3 2022	share	0.99%	69.24M	$28.33	$19.89	-29.78%	Sold -11.23% shares Q3 2022
Biotechnology Apellis Pharmaceuticals, Inc. Portfolio share: 0.99% Portfolio value: 68.80M Avg. open price: $40.42 Current price: $49.41 P/L: +22.23% Sold -16.49% shares Q3 2022	share	0.99%	68.80M	$40.42	$49.41	+22.23%	Sold -16.49% shares Q3 2022
Health Information Services Evolent Health, Inc. Portfolio share: 0.96% Portfolio value: 67.15M Avg. open price: $12.48 Current price: $28.66 P/L: +129.69% Sold -7.40% shares Q3 2022	share	0.96%	67.15M	$12.48	$28.66	+129.69%	Sold -7.40% shares Q3 2022
Healthcare Plans Humana Inc. Portfolio share: 0.93% Portfolio value: 65.11M Avg. open price: $301.97 Current price: $547.42 P/L: +81.28% Sold -7.64% shares Q3 2022	share	0.93%	65.11M	$301.97	$547.42	+81.28%	Sold -7.64% shares Q3 2022
Biotechnology CRISPR Therapeutics AG Portfolio share: 0.87% Portfolio value: 60.66M Avg. open price: $87.18 Current price: $52.11 P/L: -40.23% Bought +0.68% shares Q3 2022	share	0.87%	60.66M	$87.18	$52.11	-40.23%	Bought +0.68% shares Q3 2022
Medical Care Facilities Amedisys, Inc. Portfolio share: 0.83% Portfolio value: 57.97M Avg. open price: $179.05 Current price: $90.53 P/L: -49.44% Bought +2.35% shares Q3 2022	share	0.83%	57.97M	$179.05	$90.53	-49.44%	Bought +2.35% shares Q3 2022
Medical Care Facilities HCA Healthcare, Inc. Portfolio share: 0.75% Portfolio value: 52.52M Avg. open price: $122.95 Current price: $235.35 P/L: +91.43% Sold -2.38% shares Q3 2022	share	0.75%	52.52M	$122.95	$235.35	+91.43%	Sold -2.38% shares Q3 2022
Healthcare Plans CIGNA CORP NEW Portfolio share: 0.75% Portfolio value: 52.35M Avg. open price: $168.58 Current price: $327.39 P/L: +94.21% Sold -2.56% shares Q3 2022	share	0.75%	52.35M	$168.58	$327.39	+94.21%	Sold -2.56% shares Q3 2022
Diagnostics & Research Charles River Laboratories International, Inc. Portfolio share: 0.74% Portfolio value: 51.75M Avg. open price: $198.81 Current price: $215.11 P/L: +8.20% Bought +13.82% shares Q3 2022	share	0.74%	51.75M	$198.81	$215.11	+8.20%	Bought +13.82% shares Q3 2022
Biotechnology Celldex Therapeutics, Inc. Portfolio share: 0.73% Portfolio value: 50.59M Avg. open price: $26.96 Current price: $36.66 P/L: +35.98% Bought +94.59% shares Q3 2022	share	0.73%	50.59M	$26.96	$36.66	+35.98%	Bought +94.59% shares Q3 2022
Medical Devices Medtronic plc Portfolio share: 0.71% Portfolio value: 49.73M Avg. open price: $97.2 Current price: $78.79 P/L: -18.94% Sold -4.58% shares Q3 2022	share	0.71%	49.73M	$97.2	$78.79	-18.94%	Sold -4.58% shares Q3 2022
Medical Devices Silk Road Medical, Inc Portfolio share: 0.68% Portfolio value: 47.13M Avg. open price: $56.52 Current price: $53.65 P/L: -5.08% Bought +0.01% shares Q3 2022	share	0.68%	47.13M	$56.52	$53.65	-5.08%	Bought +0.01% shares Q3 2022
Diagnostics & Research CareDx, Inc Portfolio share: 0.64% Portfolio value: 44.27M Avg. open price: $47.29 Current price: $12.53 P/L: -73.50% Bought +2.52% shares Q3 2022	share	0.64%	44.27M	$47.29	$12.53	-73.50%	Bought +2.52% shares Q3 2022
Medical Devices Bio-Rad Laboratories, Inc. Portfolio share: 0.61% Portfolio value: 42.47M Avg. open price: $506.73 Current price: $405.79 P/L: -19.92% Bought +11.69% shares Q3 2022	share	0.61%	42.47M	$506.73	$405.79	-19.92%	Bought +11.69% shares Q3 2022
Biotechnology Exelixis, Inc. Portfolio share: 0.60% Portfolio value: 41.92M Avg. open price: $23.57 Current price: $17.22 P/L: -26.94% Sold -0.19% shares Q3 2022	share	0.60%	41.92M	$23.57	$17.22	-26.94%	Sold -0.19% shares Q3 2022
Healthcare Plans Centene Corporation Portfolio share: 0.59% Portfolio value: 41.11M Avg. open price: $51.09 Current price: $86.35 P/L: +69.00% Sold -3.20% shares Q3 2022	share	0.59%	41.11M	$51.09	$86.35	+69.00%	Sold -3.20% shares Q3 2022
Medical Devices Abiomed, Inc. Portfolio share: 0.59% Portfolio value: 40.86M Avg. open price: $268.08 Current price: $378.26 P/L: +41.10% Sold -1.86% shares Q3 2022	share	0.59%	40.86M	$268.08	$378.26	+41.10%	Sold -1.86% shares Q3 2022
Health Information Services Accolade, Inc. Portfolio share: 0.59% Portfolio value: 40.79M Avg. open price: $38.21 Current price: $8.34 P/L: -78.17% Sold -1.73% shares Q3 2022	share	0.59%	40.79M	$38.21	$8.34	-78.17%	Sold -1.73% shares Q3 2022
Medical Devices Globus Medical, Inc. Portfolio share: 0.55% Portfolio value: 38.55M Avg. open price: $51.96 Current price: $72.28 P/L: +39.11% Sold -1.45% shares Q3 2022	share	0.55%	38.55M	$51.96	$72.28	+39.11%	Sold -1.45% shares Q3 2022
Medical Devices Outset Medical, Inc. Portfolio share: 0.55% Portfolio value: 38.51M Avg. open price: $46.85 Current price: $21.42 P/L: -54.28% Bought +3.90% shares Q3 2022	share	0.55%	38.51M	$46.85	$21.42	-54.28%	Bought +3.90% shares Q3 2022
Biotechnology Halozyme Therapeutics, Inc. Portfolio share: 0.53% Portfolio value: 36.79M Avg. open price: $37.32 Current price: $55.94 P/L: +49.90% Sold -4.20% shares Q3 2022	share	0.53%	36.79M	$37.32	$55.94	+49.90%	Sold -4.20% shares Q3 2022
Diagnostics & Research Exact Sciences Corporation Portfolio share: 0.53% Portfolio value: 36.70M Avg. open price: $78.56 Current price: $45.55 P/L: -42.02% Bought +49.03% shares Q3 2022	share	0.53%	36.70M	$78.56	$45.55	-42.02%	Bought +49.03% shares Q3 2022
Diagnostics & Research Thermo Fisher Scientific Inc. Portfolio share: 0.53% Portfolio value: 36.59M Avg. open price: $362.59 Current price: $557.21 P/L: +53.67% Bought +0.45% shares Q3 2022	share	0.53%	36.59M	$362.59	$557.21	+53.67%	Bought +0.45% shares Q3 2022
Health Information Services Omnicell, Inc. Portfolio share: 0.52% Portfolio value: 36.05M Avg. open price: $87.35 Current price: $49.45 P/L: -43.39% Sold -2.71% shares Q3 2022	share	0.52%	36.05M	$87.35	$49.45	-43.39%	Sold -2.71% shares Q3 2022
Medical Devices Penumbra, Inc. Portfolio share: 0.52% Portfolio value: 35.98M Avg. open price: $173.03 Current price: $212 P/L: +22.52% Sold -1.46% shares Q3 2022	share	0.52%	35.98M	$173.03	$212	+22.52%	Sold -1.46% shares Q3 2022
Diagnostics & Research IDEXX Laboratories, Inc. Portfolio share: 0.51% Portfolio value: 35.45M Avg. open price: $329.56 Current price: $422.3 P/L: +28.14% Sold -6.00% shares Q3 2022	share	0.51%	35.45M	$329.56	$422.3	+28.14%	Sold -6.00% shares Q3 2022
Drug Manufacturers—General Pfizer Inc. Portfolio share: 0.48% Portfolio value: 33.57M Avg. open price: $50.48 Current price: $50.73 P/L: +0.50% Sold -8.18% shares Q3 2022	share	0.48%	33.57M	$50.48	$50.73	+0.50%	Sold -8.18% shares Q3 2022
Medical Devices Pacific Biosciences of California, Inc. Portfolio share: 0.45% Portfolio value: 31.57M Avg. open price: $10.46 Current price: $10.03 P/L: -4.07% Sold -8.75% shares Q3 2022	share	0.45%	31.57M	$10.46	$10.03	-4.07%	Sold -8.75% shares Q3 2022
Biotechnology Harmony Biosciences Holdings, Inc. Portfolio share: 0.42% Portfolio value: 29.10M Avg. open price: $48.62 Current price: $60.91 P/L: +25.29% Sold -6.39% shares Q3 2022	share	0.42%	29.10M	$48.62	$60.91	+25.29%	Sold -6.39% shares Q3 2022
Diagnostics & Research IQVIA Holdings Inc. Portfolio share: 0.42% Portfolio value: 29.02M Avg. open price: $197.78 Current price: $211.93 P/L: +7.15% Sold -4.97% shares Q3 2022	share	0.42%	29.02M	$197.78	$211.93	+7.15%	Sold -4.97% shares Q3 2022
Drug Manufacturers—Specialty & Generic Esperion Therapeutics, Inc. Portfolio share: 0.41% Portfolio value: 28.30M Avg. open price: $42.24 Current price: $7.49 P/L: -82.27% Sold -0.24% shares Q3 2022	share	0.41%	28.30M	$42.24	$7.49	-82.27%	Sold -0.24% shares Q3 2022
Medical Devices Zimmer Biomet Holdings, Inc. Portfolio share: 0.40% Portfolio value: 27.73M Avg. open price: $118.41 Current price: $122.3 P/L: +3.29% Sold -0.31% shares Q3 2022	share	0.40%	27.73M	$118.41	$122.3	+3.29%	Sold -0.31% shares Q3 2022
Biotechnology Mersana Therapeutics, Inc. Portfolio share: 0.40% Portfolio value: 27.59M Avg. open price: $17.78 Current price: $7.05 P/L: -60.35% Bought +4.81% shares Q3 2022	share	0.40%	27.59M	$17.78	$7.05	-60.35%	Bought +4.81% shares Q3 2022
Medical Devices TransMedics Group, Inc. Portfolio share: 0.39% Portfolio value: 27.29M Avg. open price: $20.3 Current price: $61.9 P/L: +204.86% Bought +12.75% shares Q3 2022	share	0.39%	27.29M	$20.3	$61.9	+204.86%	Bought +12.75% shares Q3 2022
Biotechnology Beam Therapeutics Inc. Portfolio share: 0.39% Portfolio value: 27.23M Avg. open price: $81.3 Current price: $44.37 P/L: -45.42% Sold -0.16% shares Q3 2022	share	0.39%	27.23M	$81.3	$44.37	-45.42%	Sold -0.16% shares Q3 2022
Biotechnology Kezar Life Sciences, Inc. Portfolio share: 0.37% Portfolio value: 26.09M Avg. open price: $4.59 Current price: $7.07 P/L: +54.00% Sold -0.13% shares Q3 2022	share	0.37%	26.09M	$4.59	$7.07	+54.00%	Sold -0.13% shares Q3 2022
Health Information Services Veeva Systems Inc. Portfolio share: 0.37% Portfolio value: 25.98M Avg. open price: $208.9 Current price: $167.24 P/L: -19.94% Sold -6.63% shares Q3 2022	share	0.37%	25.98M	$208.9	$167.24	-19.94%	Sold -6.63% shares Q3 2022
Biotechnology Legend Biotech Corporation Portfolio share: 0.37% Portfolio value: 25.51M Avg. open price: $43.09 Current price: $50.99 P/L: +18.34% Sold -0.79% shares Q3 2022	share	0.37%	25.51M	$43.09	$50.99	+18.34%	Sold -0.79% shares Q3 2022
Biotechnology MacroGenics, Inc. Portfolio share: 0.36% Portfolio value: 25.34M Avg. open price: $21.32 Current price: $6.38 P/L: -70.07% Sold -14.43% shares Q1 2022	share	0.36%	25.34M	$21.32	$6.38	-70.07%	Sold -14.43% shares Q1 2022
Medical Instruments & Supplies AtriCure, Inc. Portfolio share: 0.36% Portfolio value: 25.12M Avg. open price: $70.07 Current price: $43.65 P/L: -37.71% Bought +0.09% shares Q3 2022	share	0.36%	25.12M	$70.07	$43.65	-37.71%	Bought +0.09% shares Q3 2022
Diagnostics & Research Castle Biosciences, Inc. Portfolio share: 0.35% Portfolio value: 24.56M Avg. open price: $44.8 Current price: $24.41 P/L: -45.52% Bought +0.09% shares Q3 2022	share	0.35%	24.56M	$44.8	$24.41	-45.52%	Bought +0.09% shares Q3 2022
Medical Devices PROCEPT BioRobotics Corporation Portfolio share: 0.35% Portfolio value: 24.43M Avg. open price: $32.67 Current price: $45.58 P/L: +39.53% Sold -1.03% shares Q3 2022	share	0.35%	24.43M	$32.67	$45.58	+39.53%	Sold -1.03% shares Q3 2022
Biotechnology Adaptive Biotechnologies Corporation Portfolio share: 0.34% Portfolio value: 23.35M Avg. open price: $29.33 Current price: $8.24 P/L: -71.90% Sold -7.33% shares Q3 2022	share	0.34%	23.35M	$29.33	$8.24	-71.90%	Sold -7.33% shares Q3 2022
Biotechnology Axsome Therapeutics, Inc. Portfolio share: 0.32% Portfolio value: 22.15M Avg. open price: $59.45 Current price: $77.29 P/L: +30.01% Sold -39.24% shares Q3 2022	share	0.32%	22.15M	$59.45	$77.29	+30.01%	Sold -39.24% shares Q3 2022
Healthcare Plans CVS Health Corporation Portfolio share: 0.31% Portfolio value: 21.46M Avg. open price: $66.22 Current price: $102.01 P/L: +54.05% Sold -1.76% shares Q3 2022	share	0.31%	21.46M	$66.22	$102.01	+54.05%	Sold -1.76% shares Q3 2022
Medical Instruments & Supplies The Cooper Companies, Inc. Portfolio share: 0.31% Portfolio value: 21.45M Avg. open price: $334.71 Current price: $321.56 P/L: -3.93% Sold -0.20% shares Q3 2022	share	0.31%	21.45M	$334.71	$321.56	-3.93%	Sold -0.20% shares Q3 2022
Biotechnology Aurinia Pharmaceuticals Inc. Portfolio share: 0.31% Portfolio value: 21.40M Avg. open price: $11.45 Current price: $4.91 P/L: -57.13% Bought +6.55% shares Q3 2022	share	0.31%	21.40M	$11.45	$4.91	-57.13%	Bought +6.55% shares Q3 2022
Biotechnology BioNTech SE Portfolio share: 0.30% Portfolio value: 20.71M Avg. open price: $216.55 Current price: $166.71 P/L: -23.02% Bought +1.57% shares Q3 2022	share	0.30%	20.71M	$216.55	$166.71	-23.02%	Bought +1.57% shares Q3 2022
Biotechnology Generation Bio Co. Portfolio share: 0.28% Portfolio value: 19.26M Avg. open price: $25.62 Current price: $5.22 P/L: -79.63% Sold -1.49% shares Q2 2022	share	0.28%	19.26M	$25.62	$5.22	-79.63%	Sold -1.49% shares Q2 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 0.27% Portfolio value: 18.68M Avg. open price: $31.69 Current price: $98.48 P/L: +210.74% Sold -10.55% shares Q3 2022	share	0.27%	18.68M	$31.69	$98.48	+210.74%	Sold -10.55% shares Q3 2022
Medical Instruments & Supplies ResMed Inc. Portfolio share: 0.27% Portfolio value: 18.47M Avg. open price: $100.24 Current price: $219.35 P/L: +118.83% Sold -0.30% shares Q3 2022	share	0.27%	18.47M	$100.24	$219.35	+118.83%	Sold -0.30% shares Q3 2022
Health Information Services Privia Health Group, Inc. Portfolio share: 0.25% Portfolio value: 17.54M Avg. open price: N/A Current price: $23.52 P/L: N/A Sold -0.93% shares Q3 2022	share	0.25%	17.54M	N/A	$23.52	N/A	Sold -0.93% shares Q3 2022
Medical Instruments & Supplies Baxter International Inc. Portfolio share: 0.25% Portfolio value: 17.21M Avg. open price: $78.44 Current price: $51.3 P/L: -34.60% Sold -30.20% shares Q3 2022	share	0.25%	17.21M	$78.44	$51.3	-34.60%	Sold -30.20% shares Q3 2022
Health Information Services Phreesia, Inc. Portfolio share: 0.24% Portfolio value: 16.98M Avg. open price: $35.04 Current price: $28.04 P/L: -19.97% Sold -2.02% shares Q3 2022	share	0.24%	16.98M	$35.04	$28.04	-19.97%	Sold -2.02% shares Q3 2022
Diagnostics & Research Illumina, Inc. Portfolio share: 0.24% Portfolio value: 16.39M Avg. open price: $275.31 Current price: $213.86 P/L: -22.32% Sold -1.08% shares Q3 2022	share	0.24%	16.39M	$275.31	$213.86	-22.32%	Sold -1.08% shares Q3 2022
Biotechnology Wave Life Sciences Ltd. Portfolio share: 0.23% Portfolio value: 16.22M Avg. open price: $9.66 Current price: $4.25 P/L: -56.02% Sold -1.50% shares Q2 2022	share	0.23%	16.22M	$9.66	$4.25	-56.02%	Sold -1.50% shares Q2 2022
Medical Instruments & Supplies Hologic, Inc. Portfolio share: 0.23% Portfolio value: 16.22M Avg. open price: $49.74 Current price: $75.11 P/L: +50.99% Sold -7.17% shares Q3 2022	share	0.23%	16.22M	$49.74	$75.11	+50.99%	Sold -7.17% shares Q3 2022
Drug Manufacturers—Specialty & Generic HUTCHMED (China) Limited Portfolio share: 0.23% Portfolio value: 15.94M Avg. open price: $31.22 Current price: $13.71 P/L: -56.08% Bought +0.10% shares Q3 2022	share	0.23%	15.94M	$31.22	$13.71	-56.08%	Bought +0.10% shares Q3 2022
Medical Devices Align Technology, Inc. Portfolio share: 0.22% Portfolio value: 15.52M Avg. open price: $342.33 Current price: $187.96 P/L: -45.09% Sold -44.59% shares Q3 2022	share	0.22%	15.52M	$342.33	$187.96	-45.09%	Sold -44.59% shares Q3 2022
Biotechnology Scholar Rock Holding Corporation Portfolio share: 0.21% Portfolio value: 14.91M Avg. open price: $18.38 Current price: $7.67 P/L: -58.27% Sold -1.48% shares Q2 2022	share	0.21%	14.91M	$18.38	$7.67	-58.27%	Sold -1.48% shares Q2 2022
Medical Devices Nevro Corp. Portfolio share: 0.17% Portfolio value: 12.15M Avg. open price: $103.68 Current price: $43.47 P/L: -58.07% Sold -1.70% shares Q3 2022	share	0.17%	12.15M	$103.68	$43.47	-58.07%	Sold -1.70% shares Q3 2022
Biotechnology Regeneron Pharmaceuticals, Inc. Portfolio share: 0.17% Portfolio value: 11.97M Avg. open price: $458.64 Current price: $755.45 P/L: +64.72% Sold -1.91% shares Q3 2022	share	0.17%	11.97M	$458.64	$755.45	+64.72%	Sold -1.91% shares Q3 2022
Biotechnology ESSA Pharma Inc. Portfolio share: 0.15% Portfolio value: 10.73M Avg. open price: $23.13 Current price: $3.47 P/L: -85.00% Bought +17.74% shares Q3 2022	share	0.15%	10.73M	$23.13	$3.47	-85.00%	Bought +17.74% shares Q3 2022
Drug Manufacturers—General Amgen Inc. Portfolio share: 0.15% Portfolio value: 10.18M Avg. open price: $188.84 Current price: $285.01 P/L: +50.93% Sold -11.31% shares Q3 2022	share	0.15%	10.18M	$188.84	$285.01	+50.93%	Sold -11.31% shares Q3 2022
Health Information Services Teladoc Health, Inc. Portfolio share: 0.14% Portfolio value: 9.89M Avg. open price: $75.47 Current price: $27.08 P/L: -64.12% Sold -6.21% shares Q3 2022	share	0.14%	9.89M	$75.47	$27.08	-64.12%	Sold -6.21% shares Q3 2022
Specialty Chemicals Avantor, Inc. Portfolio share: 0.14% Portfolio value: 9.85M Avg. open price: $18.7 Current price: $22.35 P/L: +19.55% Sold -1.80% shares Q2 2022	share	0.14%	9.85M	$18.7	$22.35	+19.55%	Sold -1.80% shares Q2 2022
Biotechnology Molecular Templates, Inc. Portfolio share: 0.12% Portfolio value: 8.45M Avg. open price: $11.31 Current price: $0.5 P/L: -95.62% Bought +1.81% shares Q2 2022	share	0.12%	8.45M	$11.31	$0.5	-95.62%	Bought +1.81% shares Q2 2022
Biotechnology Black Diamond Therapeutics, Inc. Portfolio share: 0.11% Portfolio value: 7.97M Avg. open price: $17.51 Current price: $1.86 P/L: -89.38% Bought +43.25% shares Q2 2022	share	0.11%	7.97M	$17.51	$1.86	-89.38%	Bought +43.25% shares Q2 2022
Drug Manufacturers—General Biogen Inc. Portfolio share: 0.11% Portfolio value: 7.67M Avg. open price: $280.94 Current price: $292.75 P/L: +4.21% Bought +31.51% shares Q3 2022	share	0.11%	7.67M	$280.94	$292.75	+4.21%	Bought +31.51% shares Q3 2022
Health Information Services 10x Genomics, Inc. Portfolio share: 0.10% Portfolio value: 7.23M Avg. open price: $106.28 Current price: $36.57 P/L: -65.59% Sold -2.02% shares Q3 2022	share	0.10%	7.23M	$106.28	$36.57	-65.59%	Sold -2.02% shares Q3 2022
Health Information Services American Well Corporation Portfolio share: 0.09% Portfolio value: 6.35M Avg. open price: $25.47 Current price: $3.75 P/L: -85.28% Sold -16.83% shares Q1 2022	share	0.09%	6.35M	$25.47	$3.75	-85.28%	Sold -16.83% shares Q1 2022
Medical Instruments & Supplies Teleflex Incorporated Portfolio share: 0.09% Portfolio value: 6.34M Avg. open price: $322.42 Current price: $235.78 P/L: -26.87% Sold -67.20% shares Q3 2022	share	0.09%	6.34M	$322.42	$235.78	-26.87%	Sold -67.20% shares Q3 2022
Drug Manufacturers—General Gilead Sciences, Inc. Portfolio share: 0.09% Portfolio value: 6.03M Avg. open price: $59.58 Current price: $87.98 P/L: +47.68% Bought +29.74% shares Q3 2022	share	0.09%	6.03M	$59.58	$87.98	+47.68%	Bought +29.74% shares Q3 2022
Biotechnology Seagen Inc. Portfolio share: 0.08% Portfolio value: 5.87M Avg. open price: $98.68 Current price: $121.22 P/L: +22.84% Sold -13.06% shares Q3 2022	share	0.08%	5.87M	$98.68	$121.22	+22.84%	Sold -13.06% shares Q3 2022
Health Information Services Doximity, Inc. Portfolio share: 0.08% Portfolio value: 5.84M Avg. open price: $43.17 Current price: $35.38 P/L: -18.04% Bought +41.90% shares Q3 2022	share	0.08%	5.84M	$43.17	$35.38	-18.04%	Bought +41.90% shares Q3 2022
Drug Manufacturers—General Johnson & Johnson Portfolio share: 0.07% Portfolio value: 5.01M Avg. open price: $162.5 Current price: $178.78 P/L: +10.02% Bought +6.08% shares Q3 2022	share	0.07%	5.01M	$162.5	$178.78	+10.02%	Bought +6.08% shares Q3 2022
Biotechnology BioMarin Pharmaceutical Inc. Portfolio share: 0.07% Portfolio value: 4.53M Avg. open price: $80.91 Current price: $103.53 P/L: +27.95% Sold -27.47% shares Q3 2022	share	0.07%	4.53M	$80.91	$103.53	+27.95%	Sold -27.47% shares Q3 2022
Drug Manufacturers—Specialty & Generic Supernus Pharmaceuticals, Inc. Portfolio share: 0.06% Portfolio value: 4.03M Avg. open price: $36.21 Current price: $35.61 P/L: -1.66% Bought +44.75% shares Q3 2022	share	0.06%	4.03M	$36.21	$35.61	-1.66%	Bought +44.75% shares Q3 2022
Biotechnology Cytokinetics, Incorporated Portfolio share: 0.05% Portfolio value: 3.45M Avg. open price: $39.29 Current price: $38.12 P/L: -2.98% Bought +7.23% shares Q3 2022	share	0.05%	3.45M	$39.29	$38.12	-2.98%	Bought +7.23% shares Q3 2022
Diagnostics & Research Guardant Health, Inc. Portfolio share: 0.05% Portfolio value: 3.34M Avg. open price: $118.84 Current price: $51.95 P/L: -56.29% Sold -12.04% shares Q3 2022	share	0.05%	3.34M	$118.84	$51.95	-56.29%	Sold -12.04% shares Q3 2022
Drug Manufacturers—General Eli Lilly and Company Portfolio share: 0.04% Portfolio value: 3.06M Avg. open price: $81.05 Current price: $369.29 P/L: +355.66% Bought +879.36% shares Q3 2022	share	0.04%	3.06M	$81.05	$369.29	+355.66%	Bought +879.36% shares Q3 2022
Medical Devices Pulmonx Corporation Portfolio share: 0.04% Portfolio value: 2.88M Avg. open price: N/A Current price: $6.18 P/L: N/A Sold -1.80% shares Q2 2022	share	0.04%	2.88M	N/A	$6.18	N/A	Sold -1.80% shares Q2 2022
Diagnostics & Research Olink Holding AB (publ) Portfolio share: 0.04% Portfolio value: 2.79M Avg. open price: $30.67 Current price: $22 P/L: -28.26% Sold -2.02% shares Q3 2022	share	0.04%	2.79M	$30.67	$22	-28.26%	Sold -2.02% shares Q3 2022
Biotechnology Homology Medicines, Inc. Portfolio share: 0.04% Portfolio value: 2.61M Avg. open price: $18.07 Current price: $1.47 P/L: -91.86% Sold -1.49% shares Q2 2022	share	0.04%	2.61M	$18.07	$1.47	-91.86%	Sold -1.49% shares Q2 2022
Drug Manufacturers—General AstraZeneca PLC Portfolio share: 0.04% Portfolio value: 2.45M Avg. open price: $58.47 Current price: $68.42 P/L: +17.02% Sold -48.97% shares Q3 2022	share	0.04%	2.45M	$58.47	$68.42	+17.02%	Sold -48.97% shares Q3 2022
Biotechnology Bicycle Therapeutics plc Portfolio share: 0.03% Portfolio value: 2.28M Avg. open price: $37.85 Current price: $32.41 P/L: -14.38% Bought +16.23% shares Q3 2022	share	0.03%	2.28M	$37.85	$32.41	-14.38%	Bought +16.23% shares Q3 2022
Drug Manufacturers—General AbbVie Inc. Portfolio share: 0.03% Portfolio value: 2.28M Avg. open price: $80.02 Current price: $163.96 P/L: +104.89% Bought +2003.59% shares Q3 2022	share	0.03%	2.28M	$80.02	$163.96	+104.89%	Bought +2003.59% shares Q3 2022
Biotechnology Arcus Biosciences, Inc. Portfolio share: 0.03% Portfolio value: 2.18M Avg. open price: $32.09 Current price: $33.96 P/L: +5.81% Sold -7.33% shares Q3 2022	share	0.03%	2.18M	$32.09	$33.96	+5.81%	Sold -7.33% shares Q3 2022
Biotechnology Relmada Therapeutics, Inc. Portfolio share: 0.03% Portfolio value: 1.96M Avg. open price: $23.08 Current price: $4.45 P/L: -80.72% Bought +51.96% shares Q3 2022	share	0.03%	1.96M	$23.08	$4.45	-80.72%	Bought +51.96% shares Q3 2022
Medical Devices Sight Sciences, Inc. Portfolio share: 0.03% Portfolio value: 1.87M Avg. open price: N/A Current price: $11.71 P/L: N/A Sold -1.80% shares Q2 2022	share	0.03%	1.87M	N/A	$11.71	N/A	Sold -1.80% shares Q2 2022
Biotechnology Intellia Therapeutics, Inc. Portfolio share: 0.02% Portfolio value: 1.70M Avg. open price: $51.76 Current price: $42.01 P/L: -18.84% Bought +92.97% shares Q3 2022	share	0.02%	1.70M	$51.76	$42.01	-18.84%	Bought +92.97% shares Q3 2022
Oil & Gas E&P Kosmos Energy Ltd. Portfolio share: 0.02% Portfolio value: 1.64M Avg. open price: $2.27 Current price: $6.02 P/L: +165.41% Sold -22.74% shares Q2 2022	share	0.02%	1.64M	$2.27	$6.02	+165.41%	Sold -22.74% shares Q2 2022
Medical Distribution AmerisourceBergen Corporation Portfolio share: 0.02% Portfolio value: 1.61M Avg. open price: $84.54 Current price: $171.25 P/L: +102.57% Sold -8.38% shares Q3 2022	share	0.02%	1.61M	$84.54	$171.25	+102.57%	Sold -8.38% shares Q3 2022
Medical Devices NeuroPace, Inc. Portfolio share: 0.02% Portfolio value: 1.45M Avg. open price: N/A Current price: $1.58 P/L: N/A Sold -23.54% shares Q3 2022	share	0.02%	1.45M	N/A	$1.58	N/A	Sold -23.54% shares Q3 2022
Biotechnology Akero Therapeutics, Inc. Portfolio share: 0.02% Portfolio value: 1.41M Avg. open price: N/A Current price: $44.04 P/L: N/A N/A Q3 2022	share	0.02%	1.41M	N/A	$44.04	N/A	N/A Q3 2022
Biotechnology Krystal Biotech, Inc. Portfolio share: 0.02% Portfolio value: 1.27M Avg. open price: $65.66 Current price: $75.78 P/L: +15.41% Bought +36.57% shares Q3 2022	share	0.02%	1.27M	$65.66	$75.78	+15.41%	Bought +36.57% shares Q3 2022
Biotechnology Zai Lab Limited Portfolio share: 0.02% Portfolio value: 1.27M Avg. open price: $65.33 Current price: $33.74 P/L: -48.36% N/A Q3 2022	share	0.02%	1.27M	$65.33	$33.74	-48.36%	N/A Q3 2022
Medical Instruments & Supplies Repligen Corporation Portfolio share: 0.02% Portfolio value: 1.23M Avg. open price: N/A Current price: $178.61 P/L: N/A N/A Q3 2022	share	0.02%	1.23M	N/A	$178.61	N/A	N/A Q3 2022
Biotechnology Berkeley Lights, Inc. Portfolio share: 0.02% Portfolio value: 1.10M Avg. open price: $86.07 Current price: $2.77 P/L: -96.78% Bought +1.59% shares Q2 2021	share	0.02%	1.10M	$86.07	$2.77	-96.78%	Bought +1.59% shares Q2 2021
Biotechnology Seer, Inc. Portfolio share: 0.02% Portfolio value: 1.05M Avg. open price: $53.53 Current price: $6.8 P/L: -87.30% Bought +23.50% shares Q2 2021	share	0.02%	1.05M	$53.53	$6.8	-87.30%	Bought +23.50% shares Q2 2021
Diagnostics & Research Agilent Technologies, Inc. Portfolio share: 0.02% Portfolio value: 1.04M Avg. open price: $100.19 Current price: $150.01 P/L: +49.72% N/A Q3 2022	share	0.02%	1.04M	$100.19	$150.01	+49.72%	N/A Q3 2022
Medical Distribution McKesson Corporation Portfolio share: 0.01% Portfolio value: 999K Avg. open price: $318.26 Current price: $382.44 P/L: +20.17% Bought +15.81% shares Q3 2022	share	0.01%	999K	$318.26	$382.44	+20.17%	Bought +15.81% shares Q3 2022
Biotechnology Denali Therapeutics Inc. Portfolio share: 0.01% Portfolio value: 951K Avg. open price: N/A Current price: $30.94 P/L: N/A N/A Q3 2022	share	0.01%	951K	N/A	$30.94	N/A	N/A Q3 2022
Biotechnology Viridian Therapeutics, Inc. Portfolio share: 0.01% Portfolio value: 946K Avg. open price: N/A Current price: $26.84 P/L: N/A Sold -5.92% shares Q3 2022	share	0.01%	946K	N/A	$26.84	N/A	Sold -5.92% shares Q3 2022
Biotechnology BeiGene, Ltd. Portfolio share: 0.01% Portfolio value: 940K Avg. open price: $230.72 Current price: $188.71 P/L: -18.21% N/A Q3 2022	share	0.01%	940K	$230.72	$188.71	-18.21%	N/A Q3 2022
Diagnostics & Research Laboratory Corporation of America Holdings Portfolio share: 0.01% Portfolio value: 799K Avg. open price: $168.86 Current price: $236.39 P/L: +39.99% Sold -8.24% shares Q3 2022	share	0.01%	799K	$168.86	$236.39	+39.99%	Sold -8.24% shares Q3 2022
Biotechnology Inhibrx, Inc. Portfolio share: 0.01% Portfolio value: 781K Avg. open price: $22.28 Current price: $29.18 P/L: +30.97% Sold -43.21% shares Q3 2022	share	0.01%	781K	$22.28	$29.18	+30.97%	Sold -43.21% shares Q3 2022
Biotechnology Caribou Biosciences, Inc. Portfolio share: 0.01% Portfolio value: 699K Avg. open price: N/A Current price: $9.14 P/L: N/A Sold -5.69% shares Q3 2022	share	0.01%	699K	N/A	$9.14	N/A	Sold -5.69% shares Q3 2022
Drug Manufacturers—Specialty & Generic Dr. Reddy's Laboratories Limited Portfolio share: 0.01% Portfolio value: 664K Avg. open price: $55.73 Current price: $54.79 P/L: -1.69% Bought +45.88% shares Q2 2022	share	0.01%	664K	$55.73	$54.79	-1.69%	Bought +45.88% shares Q2 2022
Biotechnology Xencor, Inc. Portfolio share: 0.01% Portfolio value: 660K Avg. open price: $43.63 Current price: $29.54 P/L: -32.31% Sold -4.15% shares Q3 2022	share	0.01%	660K	$43.63	$29.54	-32.31%	Sold -4.15% shares Q3 2022
SPDR S&P 500 ETF Trust Portfolio share: 0.01% Portfolio value: 643K Avg. open price: N/A Current price: $400.01 P/L: N/A N/A Q3 2022	share	0.01%	643K	N/A	$400.01	N/A	N/A Q3 2022
Biotechnology Design Therapeutics, Inc. Portfolio share: 0.01% Portfolio value: 583K Avg. open price: N/A Current price: $13.67 P/L: N/A N/A Q3 2022	share	0.01%	583K	N/A	$13.67	N/A	N/A Q3 2022
Internet Content & Information Alphabet Inc. Portfolio share: 0.01% Portfolio value: 577K Avg. open price: $2,792.99 Current price: $99.87 P/L: -96.42% Bought +122.22% shares Q2 2022	share	0.01%	577K	$2,792.99	$99.87	-96.42%	Bought +122.22% shares Q2 2022
Biotechnology Merus N.V. Portfolio share: 0.01% Portfolio value: 509K Avg. open price: N/A Current price: $14.2 P/L: N/A N/A Q3 2022	share	0.01%	509K	N/A	$14.2	N/A	N/A Q3 2022
Drug Manufacturers—General Bristol-Myers Squibb Company Portfolio share: 0.01% Portfolio value: 502K Avg. open price: $50.84 Current price: $80.7 P/L: +58.73% Sold -71.65% shares Q3 2022	share	0.01%	502K	$50.84	$80.7	+58.73%	Sold -71.65% shares Q3 2022
SPDR S&P Oil & Gas Exploration & Production ETF Portfolio share: 0.01% Portfolio value: 486K Avg. open price: N/A Current price: $140.93 P/L: N/A N/A Q3 2022	share	0.01%	486K	N/A	$140.93	N/A	N/A Q3 2022
Drug Manufacturers—General Merck & Co., Inc. Portfolio share: 0.01% Portfolio value: 417K Avg. open price: $79.32 Current price: $110.01 P/L: +38.68% Bought +402.49% shares Q3 2022	share	0.01%	417K	$79.32	$110.01	+38.68%	Bought +402.49% shares Q3 2022
VanEck Gold Miners ETF Portfolio share: 0.00% Portfolio value: 323K Avg. open price: N/A Current price: $28.84 P/L: N/A N/A Q1 2022	share	0.00%	323K	N/A	$28.84	N/A	N/A Q1 2022
Household & Personal Products The Estée Lauder Companies Inc. Portfolio share: 0.00% Portfolio value: 291K Avg. open price: N/A Current price: $231.47 P/L: N/A Sold -40.04% shares Q1 2021	share	0.00%	291K	N/A	$231.47	N/A	Sold -40.04% shares Q1 2021
Biotechnology Opthea Limited Portfolio share: 0.00% Portfolio value: 283K Avg. open price: N/A Current price: $4.9 P/L: N/A Sold -2.08% shares Q2 2022	share	0.00%	283K	N/A	$4.9	N/A	Sold -2.08% shares Q2 2022
Semiconductors Skyworks Solutions, Inc. Portfolio share: 0.00% Portfolio value: 179K Avg. open price: $74.44 Current price: $93.74 P/L: +25.93% Sold -25.00% shares Q1 2021	share	0.00%	179K	$74.44	$93.74	+25.93%	Sold -25.00% shares Q1 2021
iShares MSCI China ETF Portfolio share: 0.00% Portfolio value: 174K Avg. open price: N/A Current price: $47.71 P/L: N/A N/A Q2 2022	share	0.00%	174K	N/A	$47.71	N/A	N/A Q2 2022
VanEck Junior Gold Miners ETF Portfolio share: 0.00% Portfolio value: 147K Avg. open price: N/A Current price: $35.4 P/L: N/A N/A Q2 2022	share	0.00%	147K	N/A	$35.4	N/A	N/A Q2 2022
Capital Markets MarketAxess Holdings Inc. Portfolio share: 0.00% Portfolio value: 147K Avg. open price: N/A Current price: $284.78 P/L: N/A Sold -19.46% shares Q1 2021	share	0.00%	147K	N/A	$284.78	N/A	Sold -19.46% shares Q1 2021
Internet Retail MercadoLibre, Inc. Portfolio share: 0.00% Portfolio value: 141K Avg. open price: N/A Current price: $881.9 P/L: N/A Sold -50.00% shares Q1 2021	share	0.00%	141K	N/A	$881.9	N/A	Sold -50.00% shares Q1 2021
Software—Application Avalara, Inc. Portfolio share: 0.00% Portfolio value: 119K Avg. open price: N/A Current price: $93.48 P/L: N/A Sold -43.48% shares Q4 2021	share	0.00%	119K	N/A	$93.48	N/A	Sold -43.48% shares Q4 2021
Specialty Business Services Dolby Laboratories, Inc. Portfolio share: 0.00% Portfolio value: 104K Avg. open price: N/A Current price: $75.65 P/L: N/A Sold -55.56% shares Q1 2022	share	0.00%	104K	N/A	$75.65	N/A	Sold -55.56% shares Q1 2022
Internet Retail Jumia Technologies AG Portfolio share: 0.00% Portfolio value: 105K Avg. open price: N/A Current price: $4.59 P/L: N/A N/A Q1 2021	share	0.00%	105K	N/A	$4.59	N/A	N/A Q1 2021
Semiconductor Equipment & Materials IPG Photonics Corporation Portfolio share: 0.00% Portfolio value: 89K Avg. open price: $154.25 Current price: $90.09 P/L: -41.59% Sold -22.22% shares Q4 2021	share	0.00%	89K	$154.25	$90.09	-41.59%	Sold -22.22% shares Q4 2021
Medical Care Facilities Acadia Healthcare Company, Inc. Portfolio share: 0.00% Portfolio value: 71K Avg. open price: N/A Current price: $85.65 P/L: N/A N/A Q3 2022	share	0.00%	71K	N/A	$85.65	N/A	N/A Q3 2022
Biotechnology United Therapeutics Corporation Portfolio share: 0.00% Portfolio value: 63K Avg. open price: $129.34 Current price: $273.72 P/L: +111.63% Bought +55.96% shares Q3 2022	share	0.00%	63K	$129.34	$273.72	+111.63%	Bought +55.96% shares Q3 2022
Medical Distribution Cardinal Health, Inc. Portfolio share: 0.00% Portfolio value: 61K Avg. open price: $68.13 Current price: $79.48 P/L: +16.65% N/A Q3 2022	share	0.00%	61K	$68.13	$79.48	+16.65%	N/A Q3 2022
Semiconductors Taiwan Semiconductor Manufacturing Company Limited Portfolio share: 0.00% Portfolio value: 53K Avg. open price: $120.42 Current price: $81.62 P/L: -32.22% N/A Q3 2022	share	0.00%	53K	$120.42	$81.62	-32.22%	N/A Q3 2022
Biotechnology Nektar Therapeutics Portfolio share: 0.00% Portfolio value: 47K Avg. open price: $28.97 Current price: $2.97 P/L: -89.75% Sold -48.61% shares Q3 2022	share	0.00%	47K	$28.97	$2.97	-89.75%	Sold -48.61% shares Q3 2022
Drug Manufacturers—Specialty & Generic Zoetis Inc. Portfolio share: 0.00% Portfolio value: 36K Avg. open price: N/A Current price: $155.33 P/L: N/A Sold -51.09% shares Q3 2022	share	0.00%	36K	N/A	$155.33	N/A	Sold -51.09% shares Q3 2022
Drug Manufacturers—Specialty & Generic Catalent, Inc. Portfolio share: 0.00% Portfolio value: 34K Avg. open price: $93.73 Current price: $50.77 P/L: -45.83% N/A Q3 2022	share	0.00%	34K	$93.73	$50.77	-45.83%	N/A Q3 2022
Airports & Air Services Grupo Aeroportuario del Sureste, S. A. B. de C. V. Portfolio share: 0.00% Portfolio value: 27K Avg. open price: N/A Current price: $241.01 P/L: N/A N/A Q4 2021	share	0.00%	27K	N/A	$241.01	N/A	N/A Q4 2021
Medical Instruments & Supplies Envista Holdings Corporation Portfolio share: 0.00% Portfolio value: 27K Avg. open price: $38.54 Current price: $33.51 P/L: -13.05% Bought +69.83% shares Q3 2022	share	0.00%	27K	$38.54	$33.51	-13.05%	Bought +69.83% shares Q3 2022
Information Technology Services Infosys Limited Portfolio share: 0.00% Portfolio value: 20K Avg. open price: N/A Current price: $19.75 P/L: N/A N/A Q4 2021	share	0.00%	20K	N/A	$19.75	N/A	N/A Q4 2021
REIT—Specialty Equinix, Inc. Portfolio share: 0.00% Portfolio value: 23K Avg. open price: N/A Current price: $684.27 P/L: N/A N/A Q4 2021	share	0.00%	23K	N/A	$684.27	N/A	N/A Q4 2021
Software—Infrastructure EVERTEC, Inc. Portfolio share: 0.00% Portfolio value: 23K Avg. open price: N/A Current price: $32.15 P/L: N/A N/A Q4 2021	share	0.00%	23K	N/A	$32.15	N/A	N/A Q4 2021
Semiconductors United Microelectronics Corporation Portfolio share: 0.00% Portfolio value: 15K Avg. open price: N/A Current price: $7.37 P/L: N/A N/A Q3 2022	share	0.00%	15K	N/A	$7.37	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Pacira BioSciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $76.32 Current price: $46.75 P/L: -38.74% Sold -100.00% shares Q3 2022	share	0.00%	0	$76.32	$46.75	-38.74%	Sold -100.00% shares Q3 2022
Biotechnology Silence Therapeutics plc Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $17.09 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$17.09	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Alkermes plc Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $50.55 Current price: $25.51 P/L: -49.53% Sold -100.00% shares Q3 2022	share	0.00%	0	$50.55	$25.51	-49.53%	Sold -100.00% shares Q3 2022
Drug Manufacturers—General Sanofi Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $44.93 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$44.93	N/A	Sold -100.00% shares Q3 2022
Health Information Services 1Life Healthcare, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $30.31 Current price: $16.74 P/L: -44.77% Sold -100.00% shares Q3 2022	share	0.00%	0	$30.31	$16.74	-44.77%	Sold -100.00% shares Q3 2022
Health Information Services Health Catalyst, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $33.74 Current price: $10.84 P/L: -67.87% Sold -100.00% shares Q3 2022	share	0.00%	0	$33.74	$10.84	-67.87%	Sold -100.00% shares Q3 2022
Medical Instruments & Supplies NovoCure Limited Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $82.85 Current price: $78 P/L: -5.85% Sold -100.00% shares Q3 2022	share	0.00%	0	$82.85	$78	-5.85%	Sold -100.00% shares Q3 2022
Biotechnology Ultragenyx Pharmaceutical Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $65.86 Current price: $39.83 P/L: -39.53% Sold -100.00% shares Q3 2022	share	0.00%	0	$65.86	$39.83	-39.53%	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Radius Health, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $18.14 Current price: $10.08 P/L: -44.43% Sold -100.00% shares Q3 2022	share	0.00%	0	$18.14	$10.08	-44.43%	Sold -100.00% shares Q3 2022
Biotechnology Kura Oncology, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $17.99 Current price: $15.82 P/L: -12.07% Sold -100.00% shares Q3 2022	share	0.00%	0	$17.99	$15.82	-12.07%	Sold -100.00% shares Q3 2022
Biotechnology Arcturus Therapeutics Holdings Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $47.78 Current price: $17.69 P/L: -62.98% Sold -100.00% shares Q3 2022	share	0.00%	0	$47.78	$17.69	-62.98%	Sold -100.00% shares Q3 2022

Showing TOP 187 BELLEVUE GROUP AG's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of BELLEVUE GROUP AG?

The biggest position of the BELLEVUE GROUP AG is Ionis Pharmaceuticals, Inc. (IONS) with 6.01% portfolio share worth of 418.57M US dollars.

Top 5 BELLEVUE GROUP AG's holdings represent 22.68% of the portfolio:

Ionis Pharmaceuticals, Inc. (IONS) – 6.01%
Vertex Pharmaceuticals Incorporated (VRTX) – 4.81%
argenx SE (ARGX) – 4.76%
Neurocrine Biosciences, Inc. (NBIX) – 4.35%
Alnylam Pharmaceuticals, Inc. (ALNY) – 2.75%

Who is the portfolio manager of BELLEVUE GROUP AG?

The portfolio manager of the BELLEVUE GROUP AG is .

What is the total asset value of the BELLEVUE GROUP AG portfolio?

BELLEVUE GROUP AG total asset value (portfolio value) is 6.97B US dollars.

Who is ?

is the portfolio manager of the BELLEVUE GROUP AG.

What is (BELLEVUE GROUP AG) fund performance?

BELLEVUE GROUP AG's quarterly performance is +2.13%, annualy -27.50%. In the past 3 years, the value of 's portfolio has increased by +15%. In the past 5 years, the value of the portfolio has increased by +52%.

What is the BELLEVUE GROUP AG CIK?

BELLEVUE GROUP AG's Central Index Key is 0001674546 .

BELLEVUE GROUP AG Holdings

BELLEVUE GROUP AG portfolio value:

BELLEVUE GROUP AG quarter portfolio value change:

BELLEVUE GROUP AG 1 year portfolio value change:

BELLEVUE GROUP AG 3 years portfolio value change:

BELLEVUE GROUP AG 5 years portfolio value change: